At close: May 8, 5:00 PM EST
VINCERX PHARMA INC by Vincerx Pharma, Inc. Analyst Ratings
VINCOTCEM
VINCERX PHARMA INC by Vincerx Pharma, Inc. Analyst Ratings and Price Targets | OTC:VINC | Benzinga
VINCERX PHARMA INC by Vincerx Pharma, Inc. has a consensus price target of $2 based on the ratings of 2 analysts. The high is $2 issued by Leerink Partners on October 8, 2024. The low is $2 issued by Leerink Partners on October 8, 2024. The 2 most-recent analyst ratings were released by Leerink Partners and Cantor Fitzgerald on October 8, 2024 and September 7, 2023, respectively. With an average price target of $3.5 between Leerink Partners and Cantor Fitzgerald, there's an implied 23078.81% upside for VINCERX PHARMA INC by Vincerx Pharma, Inc. from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Leerink Partners
1calculated from analyst ratings
Analyst Ratings for VINCERX PHARMA INC by Vincerx Pharma, Inc.
Loading calendar...
FAQ
What is the target price for VINCERX PHARMA INC by Vincerx Pharma, Inc. (VINC) stock?
The latest price target for VINCERX PHARMA INC by Vincerx Pharma, Inc. (OTCEM:VINC) was reported by Leerink Partners on October 8, 2024. The analyst firm set a price target for $2.00 expecting VINC to rise to within 12 months (a possible 13145.03% upside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for VINCERX PHARMA INC by Vincerx Pharma, Inc. (VINC)?
The latest analyst rating for VINCERX PHARMA INC by Vincerx Pharma, Inc. (OTCEM:VINC) was provided by Leerink Partners, and VINCERX PHARMA INC by Vincerx Pharma, Inc. maintained their outperform rating.
When was the last upgrade for VINCERX PHARMA INC by Vincerx Pharma, Inc. (VINC)?
There is no last upgrade for VINCERX PHARMA INC by Vincerx Pharma, Inc.
When was the last downgrade for VINCERX PHARMA INC by Vincerx Pharma, Inc. (VINC)?
There is no last downgrade for VINCERX PHARMA INC by Vincerx Pharma, Inc..
When is the next analyst rating going to be posted or updated for VINCERX PHARMA INC by Vincerx Pharma, Inc. (VINC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of VINCERX PHARMA INC by Vincerx Pharma, Inc., and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for VINCERX PHARMA INC by Vincerx Pharma, Inc. was filed on October 8, 2024 so you should expect the next rating to be made available sometime around October 8, 2025.
Is the Analyst Rating VINCERX PHARMA INC by Vincerx Pharma, Inc. (VINC) correct?
While ratings are subjective and will change, the latest VINCERX PHARMA INC by Vincerx Pharma, Inc. (VINC) rating was a maintained with a price target of $4.00 to $2.00. The current price VINCERX PHARMA INC by Vincerx Pharma, Inc. (VINC) is trading at is $0.02, which is out of the analyst’s predicted range.
